We recently developed a procedure to study fear incubation, in which rats given 100 tone-shock pairings over 10 days show low fear 2 days after conditioned fear training and high fear after 30 days. Notably, fear 2 days after 10 sessions of fear conditioning is lower than fear seen 2 days after a single session of fear conditioning, suggesting that fear is suppressed. Here, we investigate the potential role of CB1 receptor activation by endocannabinoids in this fear suppression. We subjected rats to 10 days of fear conditioning and then administered systemic injections of the CB1 receptor antagonist SR141716 before a conditioned fear test was conducted 2 days later under extinction conditions. A second test was conducted without any injections on the following day (3 days after training) to examine retention of fear extinction. SR141716 injections did not increase fear expression 2 days after extended fear conditioning or affect within-session extinction; however, it impaired retention of between-session fear extinction in the day 3 test. These data suggest that CB1 receptor activation does not suppress fear soon after extended fear conditioning in the fear incubation task.
Introduction
Fear conditioning involves pairing an initially neutral cue (e.g. a tone or distinctive place) with an aversive stimulus (e.g. footshock). After this training, the cue gains the ability to elicit an aversive reaction. In some cases, fear increases after the cessation of fear conditioning across an interval free from further stress or fear conditioning trials, a phenomenon called 'fear incubation ' (McAllister and McAllister, 1967) . [The term fear incubation has also been used in reference to generalization of the fear to other cues that were never paired with shock (Siegmund and Wotjak, 2007) or increases in conditioned responding that occur with nonreinforced presentations of the conditioned stimulus (Eysenck, 1968) . We believe these represent different phenomena compared with the one we are studying]. There are reports of increases in fear expression across the 24-h period following fear training in both humans and laboratory animals (Diven, 1937; Golin, 1961; McMichael, 1966; Houston et al., 1999; Balogh et al., 2002) . However, in most cases, there are no changes in fear over days or weeks after the first 24-h period (Gleitman and Holmes, 1967; Hendersen, 1978; Gale et al., 2004) . Because of the difficulty in reliably observing a growth of fear over time beyond the first 24-h after fear conditioning, the mechanisms of fear incubation are not well understood.
We recently developed a model in which fear, as measured by conditioned suppression of lever pressing and conditioned freezing, is low 2 days after extended fear conditioning (10 sessions of tone-footshock pairings) and is increased significantly 1 month after the end of conditioning (Pickens et al., 2009b (Pickens et al., , 2010 (Pickens et al., , 2013 . If the rats were subjected to only 1 day of fear conditioning, conditioned fear was high 2 days later and did not increase further across the subsequent month (Pickens et al., 2009b) . In our initial pharmacological investigation, we studied the role of neuropeptide Y (NPY), an anxiolytic neuropeptide involved in anxiety and stress responses (Heilig et al., 1994) , in fear incubation. We found that ventricular injections of NPY reduced both incubated fear (10 days of fear training, test after 1 month) and nonincubated fear (1 day of fear training, test after 2 days; Pickens et al., 2009a) . However blockade of the Y1 receptor involved in the anxiolytic effects of NPY did not increase the low preincubated fear seen 2 days after extended (10 day) fear conditioning, suggesting that endogenous NPY neurotransmission is not responsible for the low fear seen soon after extended training.
Here, we have examined whether endogenous cannabinoid neurotransmission is responsible for the low preincubated fear observed 2 days after extended fear conditioning or has an effect on extinction of this low preincubated fear. Moderate levels of CB1 activation have antianxiety effects (Viveros et al., 2005; Ruehle et al., 2012) . In addition, CB1 receptor antagonist injections block within-session extinction in mice (Marsicano et al., 2002; Plendl and Wotjak, 2010 ) and between-session extinction retention in mice and rats (Marsicano et al., 2002; Chhatwal et al., 2005) . CB1 knockout mice are impaired in within-session extinction (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006 Kamprath et al., , 2009 Kamprath et al., , 2011 Plendl and Wotjak, 2010) and between-session extinction retention (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2011) . Because there were already several experiments that showed the effects of SR141716 on the extinction of fear following limited fear conditioning (one to two sessions), we wanted to investigate the effects of SR141716 on conditioned fear after extended fear conditioning. The fear incubation procedure, involving low preincubated fear that is not seen after other fear conditioning procedures, provides a novel opportunity to investigate the effects of CB1 receptors. This approach can investigate whether endocannabinoids acting at CB1 receptors cause suppression of fear expression (as seen in the low preincubated fear test), in addition to the within-session and between-session extinction that is often measured using other procedures. We subjected rats to 10 days of fear conditioning and tested whether injection of the CB1 receptor antagonist/ inverse agonist SR141716 (rimonabant) 2 days later would increase low preincubated conditioned fear or slow down within-session extinction. We also tested the rats the following day (day 3) without pretest injections to examine whether SR141716 would affect betweensession extinction retention.
Methods

Subjects
All procedures followed the guidelines outlined in the 'Principles of Laboratory Animal Care' (NIH publication no. 85-23) and were approved by the local Animal Care and Use Committee. Male Long-Evans rats (total n = 31; Charles River, Raleigh, North Carolina, USA; 295-370 g on the first day of food restriction) were individually housed in a colony room under a reverse 12 h : 12 h light-dark cycle with lights off at 09:00 h. The rats were weighed and then given 4 g/day of food until they reached 85% of their weight on day 1; thereafter, they received 18-20 g/day of food. The fear incubation effect is most apparent under food restriction. Fear incubation is seen under food restriction conditions both milder and more severe than the ones used in this experiment and is not dependent on the particular food-restriction condition. However, the strongest incubation effect was seen under the conditions used here, in which the rats are restricted to 85% of their initial weights and then allowed to grow (Pickens et al., 2009b (Pickens et al., , 2010 .
Apparatus
Experiments were conducted in 12 self-administration chambers (Med Associates, St Albans, Vermont, USA). Each chamber had two levers 9 cm above the floor, but only one lever ('active', retractable lever) activated the pellet dispenser, delivering 45 mg food pellets (#F00021, 5.5% fat, 60% carbohydrate, 4.5% fiber; Bioserv, Frenchtown, New Jersey, USA). The grid floors of the chambers were connected to electric shock generators.
Procedures
We used a fear incubation protocol consisting of seven phases ( Fig. 1a) : magazine training (one session), leverpress training (five sessions), conditioned fear training (10 sessions), incubation period (2 days or 30 days), lever reacquisition (one session), cue-induced fear test (one session), and extinction test (one session). Rats were trained during the dark cycle. Sessions began with extension of the active lever and illumination of a red house light. Rats were weighed and fed after the daily sessions.
Food/lever training
Eight to nine days after the initial day of food restriction, the rats were subjected to 60 min of magazine training (pellet delivery every 125 s). The following day, two sessions were conducted, 2-4 h apart, on a fixed-interval-1 reinforcement schedule (lever presses could earn a pellet each second). These sessions ended when rats received 50 pellets (up to 1 h). The rats were then subjected to one 90-min session in which pellets were earned under a variable interval-30 (VI-30) reinforcement schedule (pellet availability for lever presses ranging from 1 to 59 s), and two daily 90-min sessions on a VI-60 schedule (pellet availability ranging from 1 to 119 s). Rats were maintained on the VI-60 schedule for the rest of the experiment.
Conditioned fear training
Conditioned fear training was conducted over 10 90-min sessions during which the rats were subjected to 10 30-s tones (2900 Hz, 20 dB above background), ranging from 3 to 14 min apart and coterminating with an electric shock (0.5 s, 0.5 mA, scrambled, shock intensity adjusted for interchamber variability), while earning pellets on a VI-60 schedule. Conditioned inhibition of lever pressing for food pellets was our measure of fear (Estes and Skinner, 1941; Hunt and Brady, 1951) . Lever presses were recorded during the 30 s before tone presentation (precue) and during the 30 s of tone presentation (cue), and were converted into a suppression ratio: Suppression ratio = [(precue -cue)/(precue + cue)]. The suppression ratio normalizes lever pressing during the tone for baseline precue responding (Annau and Kamin, 1961; Armony et al., 1997) . A value of 1 indicates total conditioned suppression of lever pressing during tone presentation (high fear). A value of 0 reflects no leverpress suppression during tone presentation (no fear). The rats assigned to the different treatments (incubation day and dose) were matched for their precue lever-press rates and suppression ratios during training.
antagonist, SR141716, before cue-induced fear tests. Rats were divided into three groups (n = 7-8/group) that received either vehicle or SR141716 (1 or 3 mg/kg, subcutaneously).
One day after the conditioned fear training phase, lever pressing was restabilized in a 90-min baseline session with no tones or shocks during the lever reacquisition phase. The following day (day 2 after training), conditioned fear to the tone was tested by presenting four 30-s tones, without shock, over 35 min The first tone was delivered after 6.5 min and subsequent tones were delivered after intertrial intervals of 4, 7, and 11 min. Rats received injections of vehicle or SR141716 (1 or 3 mg/kg, subcutaneously) 30 min before the start of the test session. On the following day (day 3 after training), the rats were subjected to a second conditioned fear test without any prior injections, to test for retention of conditioned fear extinction. The injections before the day 2 test were intended to allow for a test of the effects of SR141716 on retrieval and expression of the fear memory and within-session extinction on day 2. There were no injections before the day 3 retest, to allow for an examination of how SR141716 affected extinction learning or consolidation on the previous day without any effect on fear expression or retrieval during this test. We assessed both conditioned suppression and conditioned freezing during the initial cued fear test (test) and extinction retention test (retest). Multiple measures were used to ensure that any pattern of data seen was not dependent upon the use of a single fear measure. Freezing, defined as immobility except for movement related to breathing (Fanselow, 1980) , was measured during the precue and cue periods every 2 s (according to a metronome) by a blind rater previously shown to have inter-rater reliability of r = 0.92 compared with another blind rater. The suppression ratios and conditioned freezing across the four extinction trials were used as our measures of conditioned fear to assess the strength of the incubated fear response over repeated trials.
An additional group of rats (n = 9) was tested for conditioned fear 30-31 days after fear conditioning training. These rats were weighed and fed daily during the incubation interval, with continuation of the foodrestriction conditions. The experimental test conditions were the same as those described above, with a lever reacquisition session being conducted on day 29 after training, and two cue-induced fear tests being conducted on day 30 and day 31 after training, respectively. On the initial conditioned fear test, rats received vehicle injections 30 min before the start of the test session on day 30. The aim of including this experimental group was to verify that, under our experimental conditions, the fear levels measured on days 2 and 3 after training were lower (low preincubated fear) compared with those measured at a 1-month incubation interval.
(NIMH Chemical Synthesis and Drug Supply Program) was prepared fresh before testing. SR141716 was dissolved in 5% ethanol and 5% Tween-80 in sterile water and was injected (0, 1, and 3 mg/kg, subcutaneously) Experimental procedure: (a) timeline of the fear incubation protocol design to study low, preincubated fear. (b) Acquisition of lever pressing: total lever presses during the 90-min lever acquisition sessions (n = 31). (c) Acquisition of fear conditioning: suppression ratios across 10 sessions of tone-shock pairings (n = 31). *Different from session 1, P < 0.05. VI, variable interval.
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30 min before testing. Doses were chosen on the basis of previous studies showing effects on reinstatement of alcohol, nicotine, and oral-sucrose seeking (Cippitelli et al., 2005; De Vries et al., 2005) in rats.
Statistical analyses
All data were analyzed using Statistica 5.1 software (StatSoft, Tulsa, Oklahoma, USA). Conditioned fear training was analyzed for the conditioned suppression measure, to ensure that all groups were equated before testing. These data were analyzed using mixedfactor analysis of variance (ANOVA) for the course of training, with group (four levels: day 2 test-vehicle, day 2 test-1 mg/kg, day 2 test-3 mg/kg, or day 30-vehicle) as the between-subjects factor and training session (the 10 fear conditioning days) as the within-subjects factor. The conditioned fear training data were also analyzed using a between-subjects factor ANOVA for the last day of training, with group (4 levels: day 2 test-vehicle, day 2 test-1 mg/kg, day 2 test-3 mg/kg, day 30-vehicle) as the between-subjects factor.
Conditioned fear test data were analyzed separately for the conditioned suppression and conditioned freezing measures. For each measure, conditioned fear was compared between the day 2 test-vehicle and day 30 test-vehicle groups, to verify that fear on days 2-3 was at low preincubation levels compared with that across a 1-month period, which was increased. These data were analyzed using a mixed-factor ANOVA with incubation day (days 2-3 or days 30-31) as the between-subject factor and test/retest day (fear expression test or extinction retention) and test trial (the four test trials per day) as the within-subject factors. For each measure, conditioned fear was also compared across the three doses of SR141716 (0, 1, and 3 mg/kg) in the groups tested on days 2-3 to determine the effect of CB1 receptor blockade on low preincubated fear. These data were analyzed with a mixed-factor ANOVA with SR141716 dose (0, 1 or 3 mg/kg) as the between-subject factor and test/retest day (fear expression test or extinction retention) and test trial (the four test trials per day) as the within-subject factors. Significant main effects or interactions in the ANOVAs (P < 0.05) were followed up with post-hoc Tukey's honestly significant difference (HSD) tests.
Results
Lever-press and conditioned fear training Lever-press training led to a high rate of responding before the start of conditioned fear training (Fig. 1b) . Conditioned suppression increased from the first day of fear training but, in contrast to many of our earlier studies, did not decrease as training progressed (Fig. 1c) . This replicates an earlier finding that conditioned fear does not decrease across training with these feeding conditions (restriction to 85% of the original body weight followed by 18-20 g of food per day; Pickens et al., 2010) . An ANOVA of the suppression ratios during training showed a significant effect of training session [F (9,243) = 3.1, P < 0.01]. The groups were balanced such that there were no significant main effects or interactions with group (all F's < 1) across the 10 sessions of conditioning or during the last conditioning session.
Conditioned fear testing
As previously reported (Pickens et al., 2010) , conditioned fear (as measured by conditioned suppression of lever pressing and conditioned freezing) increased from 2 days to 1 month after extended fear conditioning. Systemic injections of SR141716 had no effect on fear expression or within-session extinction during the day 2 fear test. The lower dose of SR141716 tested (1 mg/kg) prevented the decrease in fear expression observed on day 3 (between-session extinction retention).
Statistical analyses of each fear measure demonstrated the fear incubation effect. Conditioned suppression in rats administered vehicle injections was higher on days 30-31 than on days 2-3 (Fig. 2a ). An ANOVA of conditioned suppression in the vehicle groups, with the factors of incubation day (days 2-3 or days 30-31), test/ retest day (fear expression test or extinction retention), and test trial (four test trials per day), showed significant effects of incubation day [F (1,14) = 5.4, P < 0.05], test/retest day [F (1,14) = 34.4, P < 0.01], and test trial [F (3,42) = 15.9, P < 0.01], as well as a significant test/retest day Â test trial interaction [F (3,42) = 3.6, P < 0.05]. No other interactions were significant (all F's < 1). Conditioned freezing in rats administered vehicle injections was also higher on days 30-31 than on days 2-3 (Fig. 2b ). An ANOVA of conditioned freezing in the vehicle groups, with the factors of incubation day (days 2-3 or days 30-31), test/retest day (fear expression test or extinction retention), and test trial (four test trials per day), showed significant effects of incubation day [F (1,14) = 5.3, P < 0.05], test/retest day [F (1,14) = 12.3, P < 0.01] and test trial [F (3,42) = 7.9, P < 0.01]. No other interactions were significant (all P's > 0.05).
The lower dose of SR141716 (1 mg/kg) blocked the retention of extinction of conditioned suppression at 2-3 days after extended fear training; however, neither 1 nor 3 mg/kg SR141716 had an effect on fear expression during this time (Fig. 3a ). An ANOVA of conditioned suppression during the cue, with the factors of SR141716 dose (0, 1, or 3 mg/kg), test/retest day (fear expression test or extinction retention), and test trial (four test trials per day), revealed significant effects of test/retest day [F (1,19) = 21.7, P < 0.01] and test trial [F (3,57) = 16.2, P < 0.01], and significant effects of SR141716 dose Â test/retest day [F (2,19) = 3.7, P < 0.05] and test/retest day Â test trial [F (3,57) = 5.3, P < 0.01] interactions. No other main effects or interactions were significant (all F's < 1). The significant SR141716 dose Â test/retest day interaction was followed up by post-hoc Tukey's HSD tests. This analysis demonstrated that there were no significant differences in the day 2 fear test between the groups administered the different SR141716 doses, but the group treated with 1 mg/kg SR141716 exhibited significantly higher conditioned suppression than the vehicle group in the extinction retention test the following day. Precue lever-press rates in the three groups are shown in Table 1 . An ANOVA of precue lever pressing with the factors of SR141716 dose (0, 1, or 3 mg/kg), test/ retest day (fear expression test or extinction retention), and test trial (four test trials per day) showed a significant effect of test trial [F (3,57) = 5.4, P < 0.01]. No other effects or interactions were significant (all F's < 1).
The lower dose of SR141716 blocked the retention of extinction of conditioned freezing at 2-3 days after extended fear training, but neither SR141716 dose tested (1 and 3 mg/kg) had an effect on fear expression at this time (Fig. 3b ). An ANOVA of conditioned freezing during the cue with the factors of SR141716 dose (0, 1, or 3 mg/kg), test/retest day (fear expression test or extinction retention), and test trial (four test trials per day) revealed significant effects of test/retest day [F (1,19) = 12.0, P < 0.01] and test trial [F (3,57) = 13.9, P < 0.01], and a significant SR141716 dose Â test/retest day interaction [F (2,19) = 3.6, P < 0.05]. No other main effects or interactions were significant (all P's > 0.05). The significant SR141716 dose Â test/retest day interaction was followed up by Tukey's HSD tests. This analysis demonstrated that there were no differences in the fear test between the groups administered different SR141716 doses; Conditioned fear was significantly higher after 1 month than after 2-3 days from the end of extended fear conditioning (the fear incubation effect). (a) Conditioned suppression of lever pressing. The mean (±SEM) test suppression ratios of rats tested 30 min after vehicle injection 2 or 30 days after the end of fear conditioning, and retested 24 h later without injections. (b) Conditioned freezing. Mean (±SEM) test conditioned freezing in rats tested 30 min after vehicle injections 2 or 30 days after the end of fear conditioning and retested 24 h later without injections. Left columns represent average behavior across each test session. Right columns represent trial-by-trial data across the four test trials in each test. n = 16, 7-9 per incubation day. *Different from days 2-3, P < 0.05. The low dose of SR141716 had no effect on fear expression, but impaired between-session retention of conditioned fear extinction. (a) Conditioned suppression of lever pressing. Mean (±SEM) test suppression ratios in rats tested 30 min after SR141716 injections (0, 1, or 3 mg/kg, subcutaneously) and retested 24 h later without SR141716 injections. (b) Conditioned freezing. Mean (±SEM) test conditioned freezing in rats tested 30 min after SR141716 injections (0, 1, or 3 mg/kg, subcutaneously) and retested 24 h later without SR141716 injections. Left columns represent average behavior across each test session. Right columns represent trial-by-trial data across the four test trials in each test. n = 22, 7-8 per dose. *Different from the corresponding test in the 0 mg/kg group, P < 0.05. 
Discussion
We found that the fear response, as measured by conditioned suppression of lever pressing and conditioned freezing during exposure to a discrete tone cue previously paired with shock, was higher after 1 month of 10 sessions of fear training than after 2 days. These findings replicate those from our recent studies (Pickens et al., 2009a (Pickens et al., , 2009b (Pickens et al., , 2010 demonstrating that conditioned fear following an extended training period incubates over time [also see Millenson and Dent (1971) and Rosas and Alonso (1997) for related findings]. Because previous findings demonstrated that fear is lower 2 days after extended fear training (10 sessions) than 2 days after limited fear conditioning (one session), this procedure provides an opportunity to determine whether endocannabinoids acting at CB1 receptors can suppress fear in the absence of extinction, which is not possible with the high fear seen soon after limited fear conditioning. We investigated whether the CB1 receptor antagonist/inverse agonist SR141716 would suppress the fear response 2 days after extended fear conditioning. We found no evidence that blocking CB1 receptors 'unmasks' suppressed fear expression 2 days after extended fear conditioning. We also found no evidence that blocking CB1 receptors prevents within-session fear extinction measured 2 days after training. However, the lower dose of the CB1 receptor antagonist (1 mg/kg, subcutaneously) did impair between-session retention of extinction assessed on the following day (day 3 after training). Notably, these effects were not limited to a single fear measure, as this pattern of data was consistent between two measures of conditioned fear (conditioned freezing and conditioned suppression of lever pressing).
Technical considerations
There are several methodological issues that should be considered before concluding that CB1 receptor blockade impairs retention of extinction. These include (i) the effects that systemic administration of SR141716 may have on locomotor activity or motivation to respond for food, (ii) the possibility that SR141716 is still present during the day 3 test, and (iii) the possible causes for the ineffectiveness of the higher dose of SR141716 tested (3 mg/kg, subcutaneously) on fear responding under our experimental conditions.
One important factor to consider is whether SR141716 may have caused changes in baseline locomotor activity or in motivation to earn food by lever pressing, as conditioned suppression of lever pressing would be affected by changes in baseline lever pressing. Although previous studies have found that SR141716 does not affect locomotor activity in the 1-5 mg/kg intraperitoneal range (Freedland et al., 2000; McLaughlin et al., 2003) , SR141716 can affect lever pressing for food under fixedratio schedules at these doses (Freedland et al., 2000; McLaughlin et al., 2003; De Vry and Jentzsch, 2004) . However, as can be seen in Table 1 , there were no significant changes in baseline lever-press rates or precue freezing in the tests. Therefore, it is highly unlikely that SR141716-induced changes in locomotor activity or SR141716-induced changes in motivation for food caused by food restriction are responsible for the changes in conditioned freezing or conditioned suppression of lever pressing seen in this experiment. In addition, because lever presses in our task earned food pellets, the fact that we saw the same pattern of results in our lever-pressdependent and lever-press-independent fear measures (conditioned suppression of lever pressing and conditioned freezing, respectively) suggests that changes in the motivation for food are not responsible for the effects of SR141716 in our task.
A second issue that should be addressed is whether the impairment of extinction retention seen on day 3 test, after injections of SR14716 (1 mg/kg, subcutaneously) before the day 2 test, is due to some effects on extinction learning or consolidation, or whether some residual SR1419716 still present on day 3 may interfere with the fear response on that day. Effects of residual SR141716 on behavior in the day 3 test seem unlikely for several reasons. First, experiments examining the antagonism of the effects of D
9
-THC on drug discrimination and lever pressing for food by SR141716 have estimated its functional half-life to be between B100 and 130 min, depending on the D 9 -THC dose (Jarbe et al., 2010) . Further, an experiment examining the effects of SR141716 on lever pressing for food in the absence of D
-THC estimated its half-life to be B15 h (McLaughlin et al., 2003) . In both cases, the half-life of SR141716 was less than the 24.5-h interval between SR141716 injection and the day 3 test. Second, SR141716 injection had no effect on fear expression or within-session extinction in the day 2 test. Thus, it is unlikely that the effects of SR141716 in the day 3 test were caused by residual SR141716 acutely affecting fear expression, retrieval of the fear memory, or within-session extinction during the day 3 test.
The effect of the 1 mg/kg dose, but not the 3 mg/kg dose, in our study was surprising. However, it is possible that the higher dose may have caused off-target effects (Pertwee et al., 2010) . These potential effects may be explained by a higher bioavailability of SR141716 because of the subcutaneous route of administration or the potential decreased uptake of the highly lipophilic SR141716 into adipose tissue (Katoch-Rouse et al., 2003) in food-restricted animals with lower body fat.
No unmasking of fear by blocking CB1 receptors
In previous studies, we have shown that a single session of fear conditioning, using the same parameters as in the extended fear training used to demonstrate fear incubation, causes high fear in a test 2 days later (Pickens et al., 2009a (Pickens et al., , 2009b . However, after extended fear conditioning, fear is relatively low. This is in accordance with previous studies showing that, with relatively mild footshock parameters (0.5 mA, but not stronger), there is a nonmonotonic fear acquisition curve such that extended training causes lower fear expression than limited training (Annau and Kamin, 1961; Millenson and Hendry, 1967) . It seems likely that fear is suppressed 2 days after extended fear training, although the neurobiological basis of this suppression of fear is unknown. We have previously shown that the NPY Y1 antagonist BIBO 3304 did not increase low preincubated fear (Pickens et al., 2009a) , suggesting that changes in NPY signaling are not responsible for the low fear 2 days after extended fear training. Another promising candidate was the endocannabinoids, as moderate levels of CB1 activation have antianxiety effects (Viveros et al., 2005; Ruehle et al., 2012) and can improve extinction retention (GunduzCinar et al., 2012 ). The present experiment tested whether endocannabinoids, acting at the CB1 receptor, suppress fear. However, blockade of the CB1 receptors had no effect on fear expression on day 2, as assayed using two different measures of conditioned fear, suggesting that CB1 activity did not suppress fear before fear incubation under these experimental conditions. CB1 blockade prevents between-session, but not within-session, extinction
We found evidence for an effect of CB1 receptor blockade on between-session extinction, but not within-session extinction. The effect on between-session extinction retention is in line with findings from other laboratories, in which CB1 receptor blockade using SR141716 before extinction sessions after limited fear conditioning (one to two sessions) caused an impairment in fear extinction retention 24 h later (Marsicano et al., 2002; Chhatwal et al., 2005 ; but see Plendl and Wotjak, 2010) . However, several other studies have also demonstrated an effect of CB1 receptor antagonists or CB1 receptor genetic knockout on within-session extinction (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006 Kamprath et al., , 2009 Kamprath et al., , 2011 Plendl and Wotjak, 2010) .
There are several potential reasons why we did not find an effect of CB1 blockade on within-session extinction. It appears that the effects of CB1 receptor antagonists on within-session and between-session extinction are dissociable, depending on the brain site affected. Injection of the CB1 receptor antagonist AM251 into the central amygdala impaired within-session extinction, but not between-session extinction, whereas injection of AM251 into the basolateral amygdala impaired between-session extinction retention, but not within-session extinction (Kamprath et al., 2011) . Thus, our systemic injections may have had a greater effect on the basolateral amygdala than on the central amygdala.
Alternatively, our experiment had several methodological differences compared with previous experiments in which CB1 blockade or knockout impaired within-session extinction, including differences in species, feeding conditions, and the particular method of measuring fear or shock intensity used in fear conditioning. Previous experiments that have demonstrated impairments in within-session extinction have investigated free-fed mice with no concurrent operant task (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006 Kamprath et al., , 2009 Kamprath et al., , 2011 Plendl and Wotjak, 2010) . In contrast, we investigated food-restricted rats performing a concurrent lever-press task, which more closely resembles the human condition in which people maintain relatively stable weights over time, and there are goals and tasks to be accomplished that compete for control of behavior with aversive emotional reactions. Thus, species differences, task differences, or differences in feeding conditions could account for the different effects of a CB1 receptor antagonist on fear extinction. Notably, food restriction can affect the levels of endocannabinoids and CB1 receptors (Hanus et al., 2003; Bello et al., 2012) , and this may change the effects of a CB1 receptor antagonist at the CB1 receptor. It is unclear which feeding conditions more closely resemble the human condition, although it is possible that the normal function of CB1 receptors in humans maintaining stable body weights more closely resembles that seen in our food-restricted rats.
However, the particular shock intensity and/or the long intertrial intervals (ITIs) between the extinction trials may also account for the lack of an effect of the CB1 receptor antagonist on within-session extinction. A previous experiment in mice found that CB1 knockout mice were impaired in extinction of fear after conditioning using 0.7 or 1.5 mA shocks, but not after conditioning using 0.5 mA shocks or shocks at the pain threshold of the mice (Kamprath et al., 2009) . Our experiment used 0.5 mA shocks in rats, whose electrical resistance is higher. In contrast, previous experiments demonstrating an effect of CB1 receptor blockade on within-session extinction used 0.7 mA or higher shock intensity in mice with a lower electrical resistance (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006 Kamprath et al., , 2009 Kamprath et al., , 2011 Plendl and Wotjak, 2010) . All the previous experiments demonstrating impaired within-session extinction used either a single 180-200-s tone for extinction or a series of discrete tones with an average ITI of 80 s (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006 Kamprath et al., , 2009 Kamprath et al., , 2011 Plendl and Wotjak, 2010) . In contrast, we gave a series of discrete trials during extinction with an average ITI of 440 s. The effects of CB1 receptors on within-session extinction have been suggested to be because of their role in a habituation-like process (Kamprath et al., 2006) . However, a nonassociative habituation-like process has been suggested to play a larger role in within-session extinction with massed extinction trials (shorter ITIs; Delamater, 2004) . Therefore, it is possible that CB1 receptors are not necessary for within-session extinction in our task because the longer ITIs used here cause extinction to occur through a process other than habituation.
Our results suggest that within-session and betweensession extinction are dissociable [as in the study by Plendl and Wotjak (2010) , although they found the opposite pattern of CB1 receptor involvement]. Our findings also replicate previous findings from other laboratories that between-session extinction, which represents the long-term memory from the extinction manipulation, is disrupted by CB1 receptor blockade (Marsicano et al., 2002; Chhatwal et al., 2005) . However, we failed to replicate the findings from other laboratories that within-session extinction, which is often attributed to nonassociative processes that occur during the nonreinforced presentations of the conditioned stimulus, is also impaired by CB1 receptor blockade (Marsicano et al., 2002; Cannich et al., 2004; Kamprath et al., 2006 Kamprath et al., , 2009 Kamprath et al., , 2011 Plendl and Wotjak, 2010) . It is unclear whether this is due to longer ITIs causing within-session extinction to proceed through different mechanisms that are CB1-receptor-independent, due to lower shock intensities causing a fear memory that does not require CB1 receptors for extinction, or due to some other methodological difference.
Conclusion
Although blockade of CB1 receptors with SR141716 prevented between-session retention of extinction, we found no role for CB1 receptors in within-session extinction or in fear expression 2 days after extended fear conditioning. To the best of our knowledge, this is the first demonstration that CB1 receptor blockade can impair between-session extinction of conditioned suppression of lever pressing. These findings also suggest that endocannabinoids acting at the CB1 receptor do not suppress fear and cause the low 'preincubated' fear seen 2 days after extended fear conditioning. Further work will need to be conducted to investigate other neural systems involved in fear extinction, habituation, or anxiety responses to determine the mechanism behind the suppression of fear.
